MYC and cancer: Similarly, another molecule, BTYNB [67], was identified for its potent inhibition of the same interaction, effectively downregulating c-Myc mRNA and protein levels, leading to decreased proliferation and growth in cancer cells, especially in ovarian and melanoma models.